|
|
|
|
|
Legal status
Application deemed to be withdrawn
| (51) | INT.CL.: (2006.01) |
A61K 38/22 A61P 29/00 |
| (11) | Number of the document | |
| (13) | Kind of document | A |
| (21) | Application number | 96-079 |
| (22) | Date of filing the application | 1996-05-31 |
| (41) | Date of publication of the application | 1996-10-25 |
| (45) | Date of publication of patent |
| (86) | Number | PCT/US94/12621 |
| Date | 1994-11-02 |
| (87) | Number | WO 95/12416 |
| Date | 1995-05-11 |
| (30) | Number | Date | Country code |
| 146520 | 1993-11-02 | US |
| (71) |
NEUROBIOLOGICAL TECHNOLOGIES, INC.,
1440 Regatta Boulevard, Richmond, CA 94804,
US
|
| (72) |
Irwin A. BRAUDE, US
|
| (73) |
NEUROBIOLOGICAL TECHNOLOGIES, INC.,
1440 Regatta Boulevard, Richmond, CA 94804,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | USE OF CORTICOTROPIN-RELEASING FACTOR FOR THE MANUFACTURE OF A MEDICAMENTS |